SCHEMBL1436216

SCHEMBL1436216

CN(O)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.52
CES1 P23141 2/20 0.52
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
CYP1A2 P05177 1/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 2/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
P2RX7 Q99572 1/20 0.46
NPC1 O15118 1/20 0.46
TACR1 P25103 1/20 0.46
CA12 O43570 1/20 0.45
CA3 P07451 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3282793 0.88 HPGD (0.50) MAPTHPGDALDH1A1
SCHEMBL3630523 0.84 ALDH1A1 (0.59) CES2CES1ALOX15TSHRCYP1A2
SCHEMBL25060930 0.81 ALDH1A1 (0.48) MAPTHPGDALDH1A1
SCHEMBL25212250 0.80 CES2 (0.50) CES2CES1ALOX15TSHRCYP1A2
SCHEMBL93592 0.79 ALDH1A1 (0.54) CES2CES1HPGDALDH1A1TDP1
SCHEMBL11004534 0.78 CES2 (0.48) CES2CES1ALOX15TSHRCYP1A2
SCHEMBL22259649 0.78 HPGD (0.53) CES2CES1ALOX15TSHRCYP1A2
SCHEMBL11210006 0.78 CES2 (0.48) CES2CES1ALOX15TSHRCYP1A2
SCHEMBL3300602 0.77 ALDH1A1 (0.64) ALOX15TSHRMAPTHPGDALDH1A1
SCHEMBL623946 0.77 PKM (0.56) CES2CES1ALOX15TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362511-B1 Protective solution for preventing ischaemia KOEHLER CHEMIE DR FRANZ (DE) 2011-03-30 EP claimed
CN-100448440-C Protective solution for preventing local ischemic damage FRANTZ KOLER DR CHEMICAL GMBH (DE) 2009-01-07 CN claimed
CN-1480132-A Protective solution for preventing local ischemic damage �����ġ����ղ�ʿ��ѧ���޹�˾ 2004-03-10 CN claimed
US-20030215781-A1 Protective solutions for organs DR. FRANZ KOEHLER CHEMIE GMBH (DE) 2003-11-20 US claimed
EP-1362511-A1 Protective solution for preventing ischaemia Dr. Franz Köhler Chemie GmbH (DE) 2003-11-19 EP claimed
US-9603354-B2 Protective solutions for organs DR. FRANZ KOEHLER CHEMIE GMBH (DE) 2017-03-28 US disclosed
US-7977383-B2 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives DR. FRANZ KOEHLER CHEMIE GMBH (DE) 2011-07-12 US disclosed
EP-1362511-B1 Protective solution for preventing ischaemia KOEHLER CHEMIE DR FRANZ (DE) 2011-03-30 EP disclosed
EP-1859679-B1 Protective solution for preventing ischaemia damage KOEHLER CHEMIE DR FRANZ (DE) 2009-10-28 EP disclosed
CN-100448440-C Protective solution for preventing local ischemic damage FRANTZ KOLER DR CHEMICAL GMBH (DE) 2009-01-07 CN disclosed
EP-1859679-A1 Protective solution for preventing ischaemia damage Dr. Franz Köhler Chemie GmbH (DE) 2007-11-28 EP disclosed
CN-1480132-A Protective solution for preventing local ischemic damage �����ġ����ղ�ʿ��ѧ���޹�˾ 2004-03-10 CN disclosed
US-20030215781-A1 Protective solutions for organs DR. FRANZ KOEHLER CHEMIE GMBH (DE) 2003-11-20 US disclosed
EP-1362511-A1 Protective solution for preventing ischaemia Dr. Franz Köhler Chemie GmbH (DE) 2003-11-19 EP disclosed
EP-0115156-A2 Light sensitive composition FUJI PHOTO FILM CO., LTD. (JP) 1984-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030215781-A1 Protective solutions for organs GLS, CA1, SI CES2 1601/4885CES1 1096/4885ALOX15 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.